Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Yena Lee, BSc
JCP
Correction
Correction: Oral Ketamine for Depression
April 22, 2020
Joshua D. Rosenblat
,
Andre F. Carvalho
,
Madeline Li
, et al
JCP
Original Research
Psoriasis and Risk of Dementia
May 14, 2019
Find out in this population-based NHIRD study which treatments used for psoriasis can also stave off dementia, another inflammatory disease, and whether the type of dementia is a key...
Kuan-Lun Huang
,
Chiung-Chi Yeh
,
Shu-I Wu
, et al
JCP
Review Article
Oral Ketamine for Depression
April 16, 2019
Intravenous ketamine has rapid and robust antidepressant effects. Read this systematic review to learn if oral ketamine also has efficacy and tolerability in depressed individuals.
Joshua D. Rosenblat
,
Andre F. Carvalho
,
Madeline Li
, et al
JCP
Original Research
THINC-it Validation for MDD
August 23, 2017
Cognitive dysfunction greatly affects functional outcome in patients with major depressive disorder, but existing tools to measure cognition in depression are inadequate. Read this article to see if the...
Roger S. McIntyre
,
Michael W. Best
,
Christopher R. Bowie
, et al
JCP
Review Article
Pharmacogenomic Testing and MDD Outcomes
June 28, 2017
In theory, pharmacogenomic testing in patients with depression can improve clinical outcomes by guiding antidepressant selection and dosing. This review looks at the current evidence to evaluate the clinical...
Joshua D. Rosenblat
,
Yena Lee
,
Roger S. McIntyre
